health

Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers

By
1 Mins read
32
0
Share
Reading Time: < 1 minute

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s (Alamy/PA) -

Drugs that are said to slow the progression of Alzheimer’s disease “make no meaningful difference to patients” while increasing the risk of swelling and bleeding  Read More

32
0
Share
Related posts
health

Food poisoning kills more than 1.5 million people a year, new analysis shows

By
1 Mins read
Reading Time: < 1 minuteUnsafe food kills more than 1.5 million people a year and causes cases of more than 200 diseases, research from the World…
health

New parents need more guidance on safe use of baby slings, researchers say after six-week-old boy died during hands-free breastfeeding

By
1 Mins read
Reading Time: < 1 minuteNew parents should be given more guidance on the safe use of baby slings, researchers said today. Read More
health

Weapons Looted During Libyan War Found With Terrorists In Nigeria –UN

By
1 Mins read
Reading Time: < 1 minuteThe United Nations said some weapons looted during the Libyan conflict in 2011 have ended up in the hands of extremist groups…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.